7β-Hydroxy-epiandrosterone-mediated regulation of the prostaglandin synthesis pathway in human peripheral blood monocytes

Steroids

Volumn 73, Issue 11, 2008, Pages 1148-1159

  Le Mée, Sandrine ^a   Hennebert, Olivier ^a   Ferrec, Claude ^b   Wülfert, Ernst ^c   Morfin, Robert ^a  

^a Bioinformatique et Chimie Moléculaire   (France)

^b INSERM   (France)

^c Hunter Fleming Ltd   (United Kingdom)

Author keywords

15 deoxy prostaglandin 12,14 J2; DHEA; Inflammation; PPAR ; Prostaglandin D2; Prostaglandin E2

Indexed keywords

15 DEOXYPROSTAGLANDIN DELTA12,14 J2; 7BETA HYDROXYEPIANDROSTERONE; CYCLOOXYGENASE 2; DELTA12 PROSTAGLANDIN J2; EPIANDROSTERONE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PRASTERONE; PROSTAGLANDIN D SYNTHASE; PROSTAGLANDIN D2; PROSTAGLANDIN E SYNTHASE; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA; 15 DEOXYPROSTAGLANDIN J2; 15-DEOXYPROSTAGLANDIN J2; 7 HYDROXYANDROSTERONE; 7-HYDROXYANDROSTERONE; ANDROSTERONE; DRUG DERIVATIVE; ISOMERASE; LIPOCALIN; PROSTAGLANDIN R2 D ISOMERASE; PROSTAGLANDIN R2 D-ISOMERASE;

ADULT; ARTICLE; CELL CULTURE; CELL LEVEL; CELL PROTECTION; CONTROLLED STUDY; CULTURE MEDIUM; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; INFLAMMATION; MALE; MONOCYTE; NUCLEOTIDE SEQUENCE; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; QUANTITATIVE ASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; BIOLOGICAL MODEL; BIOSYNTHESIS; CHEMICAL STRUCTURE; CHEMISTRY; DOSE RESPONSE; DRUG EFFECT; GENE EXPRESSION; GENETICS; METABOLISM; TIME;

ANDROSTERONE; CELLS, CULTURED; CULTURE MEDIA; CYCLOOXYGENASE 2; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION; HUMANS; INTRAMOLECULAR OXIDOREDUCTASES; LIPOCALINS; MODELS, BIOLOGICAL; MOLECULAR STRUCTURE; MONOCYTES; PPAR GAMMA; PROSTAGLANDIN D2; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 47149090345     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.steroids.2008.05.001     Document Type: Article

References (55)

1. Chalbot S., and Morfin R. Human liver S9 fractions: metabolism of dehydroepiandrosterone, epiandrosterone, and related 7-hydroxylated derivatives. Drug Metab Dispos 33 (2005) 563-569
2. Morfin R., and Starka L. Neurosteroid 7-hydroxylation products in the brain. Int Rev Neurobiol 46 (2001) 79-95
3. Rose K.A., Stapleton G., Dott K., Kieny M.P., Best R., Schwarz M., et al. Cyp7b, a novel brain cytochrome p450, catalyzes the synthesis of neurosteroids 7 alpha-hydroxy dehydroepiandrosterone and 7 alpha-hydroxy pregnenolone. Proc Natl Acad Sci USA 94 (1997) 4925-4930
4. Wu Z.L., Martin K.O., Javitt N.B., and Chiang J.Y.L. Structure and functions of human oxysterol 7 alpha-hydroxylase cDNAs and gene CYP7B1. J Lipid Res 40 (1999) 2195-2203
5. Hennebert O., Chalbot S., Alran S., and Morfin R. Dehydroepiandrosterone 7alpha-hydroxylation in human tissues: possible interference with type 1 11beta-hydroxysteroid dehydrogenase-mediated processes. J Steroid Biochem Mol Biol 104 (2007) 326-333
6. Hennebert O., Pernelle C., Ferroud C., and Morfin R. 7alpha- and 7beta-hydroxy-epiandrosterone as substrates and inhibitors for the human 11beta-hydroxysteroid dehydrogenase type 1. J Steroid Biochem Mol Biol 105 (2007) 159-165
7. Hennebert O., Le Mee S., Pernelle C., and Morfin R. 5Alpha-androstane-3beta,7alpha,17beta-triol and 5alpha-androstane-3beta,7beta, 17beta-triol as substrates for the human 11beta-hydroxysteroid dehydrogenase type 1. Steroids 72 (2007) 855-864
8. Muller C., Pompon D., Urban P., and Morfin R. Inter-conversion of 7alpha- and 7beta-hydroxy-dehydroepiandrosterone by the human 11beta-hydroxysteroid dehydrogenase type 1. J Steroid Biochem Mol Biol 99 (2006) 215-222
9. Hill M., Lapcik O., Havlikova H., Morfin R., and Hampl R. 7-Hydroxydehydroepiandrosterone epimers in human serum and saliva: comparison of gas chromatography-mass spectrometry and radioimmunoassay. J Chromatogr A 935 (2001) 297-307
10. Lapcik O., Hampl R., Hill M., Bicikova M., and Starka L. Immunoassay of 7-hydroxysteroids. 1. Radioimmunoassay of 7 beta-hydroxydehydroepiandrosterone. J Steroid Biochem Mol Biol 67 (1998) 439-445
11. Lapcik O., Hampl R., Hill M., and Starka L. Immunoassay of 7-hydroxysteroids. 2. Radioimmunoassay of 7 alpha-hydroxy-dehydroepiandrosterone. J Steroid Biochem Mol Biol 71 (1999) 231-237
12. Morfin R., and Courchay G. Pregnenolone and dehydroepiandrosterone as precursors of native 7-hydroxylated metabolites which increase the immune response in mice. J Steroid Biochem Mol Biol 50 (1994) 91-100
13. Lafaye P., Chmielewski V., Nato F., Mazie J.C., and Morfin R. The 7alpha-hydroxysteroids produced in human tonsils enhance the immune response to tetanus toxoid and Bordetella pertussis antigens. Biochim Biophys Acta 1472 (1999) 222-231
14. Pringle A.K., Schmidt W., Deans J.K., Wulfert E., Reymann K.G., and Sundstrom L.E. 7-Hydroxylated epiandrosterone (7-OH-EPIA) reduces ischaemia-induced neuronal damage both in vivo and in vitro. Eur J Neurosci 18 (2003) 117-124
15. Dudas B., Hanin I., Rose M., and Wulfert E. Protection against inflammatory neurodegeneration and glial cell death by 7beta-hydroxy epiandrosterone, a novel neurosteroid. Neurobiol Dis 15 (2004) 262-268
16. 2 alpha and related enzymes in postmortem human brain. J Neurochem 43 (1984) 71-82
17. Wong P.T., Mcgeer P.L., and McGeer E.G. Decreased prostaglandin synthesis in postmortem cerebral cortex from patients with Alzheimer's disease. Neurochem Int 21 (1992) 197-202
18. 2 accelerate the recovery of cutaneous barrier disruption induced by mechanical scratching in mice. Eur J Pharmacol 518 (2005) 56-62
19. Kim J., Yang P., Suraokar M., Sabichi A.L., Llansa N.D., Mendoza G., et al. Suppression of prostate tumor cell growth by stromal cell prostaglandin D synthase-derived products. Cancer Res 65 (2005) 6189-6198
20. 2. Am J Physiol Endocrinol Metab 289 (2005) E62-E67
21. Gosset P., Pichavant M., Faveeuw C., Bureau F., Tonnel A.B., Trottein F., et al. D2 affects the differentiation and functions of human dendritic cells: impact on the T cell response. Eur J Immunol 35 (2005) 1491-1500
22. 2 mediates neuronal protection via the DP1 receptor. J Neurochem 92 (2005) 477-486
23. 2 cause potent neuroprotection after experimental stroke through noncompletely overlapping mechanisms. J Cereb Blood Flow Metab 26 (2006) 218-229
24. 2 protects brain from ischemia-reperfusion injury. Arterioscler Thromb Vasc Biol 26 (2006) 481-487
25. 2-mediated protection of brain after experimental cerebral ischemia in rat. Brain Res 1096 (2006) 196-203
26. Wayman N.S., Hattori Y., McDonald M.C., Mota-Filipe H., Cuzzocrea S., Pisano B., et al. Ligands of the peroxisome proliferator-activated receptors (PPAR-gamma and PPAR-alpha) reduce myocardial infarct size. FASEB J 16 (2002) 1027-1040
27. 2 reduces the organ injury in hemorrhagic shock. Shock 22 (2004) 555-561
28. Dulos J., Verbraak E., Bagchus W.M., Boots A.M., and Kaptein A. Severity of murine collagen-induced arthritis correlates with increased CYP7B activity: enhancement of dehydroepiandrosterone metabolism by interleukin-1beta. Arthritis Rheum 50 (2004) 3346-3353
29. Dulos J., van der Vleuten M.A., Kavelaars A., Heijnen C.J., and Boots A.M. CYP7B expression and activity in fibroblast-like synoviocytes from patients with rheumatoid arthritis: regulation by proinflammatory cytokines. Arthritis Rheum 52 (2005) 770-778
30. Haworth O., and Buckley C.D. Resolving the problem of persistence in the switch from acute to chronic inflammation. Proc Natl Acad Sci USA 104 (2007) 20647-20648
31. 2 and 15-deoxyDelta12 14 PGJ2. Proc Natl Acad Sci USA 104 (2007) 20979-20984
32. Trifan O.C., and Hla T. Cyclooxygenase-2 modulates cellular growth and promotes tumorigenesis. J Cell Mol Med 7 (2003) 207-222
33. Debey S., Schoenbeck U., Hellmich M., Gathof B.S., Pillai R., Zander T., et al. Comparison of different isolation techniques prior gene expression profiling of blood derived cells: impact on physiological responses, on overall expression and the role of different cell types. Pharmacogenomics J 4 (2004) 193-207
34. Katial R.K., Sachanandani D., Pinney C., and Lieberman M.M. Cytokine production in cell culture by peripheral blood mononuclear cells from immunocompetent hosts. Clin Diagn Lab Immunol 5 (1998) 78-81
35. de Jonge H.J., Fehrmann R.S., de Bont E.S., Hofstra R.M., Gerbens F., Kamps W.A., et al. Evidence based selection of housekeeping genes. PLoS ONE 2 (2007) e898
36. 2: the anti-inflammatory prostaglandin?. Clin Immunol 114 (2005) 100-109
37. 2 attenuates the development of colon injury caused by dinitrobenzene sulphonic acid in the rat. Br J Pharmacol 138 (2003) 678-688
38. 2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut. Br J Pharmacol 140 (2003) 366-376
39. Ajuebor M.N., Singh A., and Wallace J.L. Cyclooxygenase-2-derived prostaglandin D(2) is an early anti-inflammatory signal in experimental colitis. Am J Physiol Gastrointest Liver Physiol 279 (2000) G238-G244
40. Clark R.B. The role of PPARs in inflammation and immunity. J Leukocyte Biol 71 (2002) 388-400
41. Jiang C., Ting A.T., and Seed B. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 391 (1998) 82-86
42. 2 via the phosphatidylinositol 3-kinase and Akt pathway. J Biol Chem 282 (2007) 5356-5366
43. Rossi A., Kapahi P., Natoli G., Takahashi T., Chen Y., Karin M., et al. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase. Nature 403 (2000) 103-108
44. 2 inhibits the expression of proinflammatory genes in human blood monocytes via a PPAR-gamma-independent mechanism. Biochem Biophys Res Commun 302 (2003) 415-420
45. Hennebert O., Pelissier M.A., Le Mée S., Wülfert E., and Morfin R. Anti-inflamatory effects and changes in prostaglandin patterns induced by 7β-hydroxy-epiandrosterone in rats with colitis. J Steroid Biochem Mol Biol 110 (2008) 255-262
46. Kim S.B., Chalbot S., Pompon D., Jo D.H., and Morfin R. The human cytochrome P4507B1: catalytic activity studies. J Steroid Biochem Mol Biol 92 (2004) 383-389
47. 14C-labelled 5α-androstane-3β,17β-diol. J Steroid Biochem 14 (1981) 663-669
48. Hampl R., Hill M., and Starka L. 7-Hydroxydehydroepiandrosterone epimers in the life span. J Steroid Biochem Mol Biol 78 (2001) 367-372
49. Kim S.B., Hill M., Kwak Y.T., Hampl R., Jo D.H., and Morfin R. Neurosteroids: cerebrospinal fluid levels for Alzheimer's disease and vascular dementia diagnostics. J Clin Endocrinol Metab 88 (2003) 5199-5206
50. Takahashi P.Y., Votruba P., Abu-Rub M., Mielke K., and Veldhuis J.D. Age attenuates testosterone secretion driven by amplitude-varying pulses of recombinant human luteinizing hormone during acute gonadotrope inhibition in healthy men. J Clin Endocrinol Metab 92 (2007) 3626-3632
51. Kuramochi H., Vallbohmer D., Uchida K., Schneider S., Hamoui N., Shimizu D., et al. Quantitative, tissue-specific analysis of cyclooxygenase gene expression in the pathogenesis of Barrett's adenocarcinoma. J Gastrointest Surg 8 (2004) 1007-1016
52. Li X., Afif H., Cheng S., Martel-Pelletier J., Pelletier J.P., Ranger P., et al. Expression and regulation of microsomal prostaglandin E synthase-1 in human osteoarthritic cartilage and chondrocytes. J Rheumatol 32 (2005) 887-895
53. Quinkler M., Bujalska I.J., Tomlinson J.W., Smith D.M., and Stewart P.M. Depot-specific prostaglandin synthesis in human adipose tissue: a novel possible mechanism of adipogenesis. Gene 380 (2006) 137-143
54. Cardell L.O., Hagge M., Uddman R., and Adner M. Downregulation of peroxisome proliferator-activated receptors (PPARs) in nasal polyposis. Respir Res 6 (2005) 132
55. Vandesompele J., De Preter K., Pattyn F., Poppe B., Van Roy N., De Paepe A., et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3 (2002) [RESEARCH0034]